Key result
Calcipotriol plus cisplatin significantly suppressed the activated hepatic stellate cell-enhanced tumor progression of heat-treated residual hepatocellular carcinoma by inhibiting periostin expression and increasing apoptosis.
Calcipotriol inhibits the periostin-mediated progression of residual hepatocellular carcinoma induced by activated hepatic stellate cells after sublethal heat treatment.
Activated HSCs may accelerate residual HCC progression after incomplete ablation; hypothesis-generating for HSC-targeted therapies pending clinical validation.
BACKGROUND: Incomplete thermal ablation may induce invasiveness of hepatocellular carcinoma (HCC). Here, we investigated whether activated hepatic stellate cells (HSCs) would accelerate the progression of residual HCC after sublethal heat treatment, and thus sought to identify the potential targets. METHODS: Hepatocellular carcinoma cells were exposed to sublethal heat treatment and then cultured with the conditioned medium from activated HSCs (HSC-CM). The cell proliferation, migration, invasion and parameters of epithelial-mesenchymal transition (EMT) were analyzed. In vivo tumor progression of heat-treated residual HCC cells inoculated with activated HSCs was studied in nude mice. RESULTS: HSC-CM significantly enhanced the proliferation, motility, invasion, prominent EMT activation and decreased apoptosis of heat-exposed residual HCC cells. These increased malignant phenotypes were markedly attenuated by neutralizing periostin (POSTN) in HSC-CM. Furthermore, exogenous POSTN administration exerted the similar effects of HSC-CM on heat-treated residual HCC cells. POSTN induced the prominent activation of p52Shc and ERK1/2 via integrin β1 in heat-exposed residual HCC cells. Vitamin D analog calcipotriol blocked POSTN secretion from activated HSCs. Calcipotriol plus cisplatin significantly suppressed the activated HSCs-enhanced tumor progression of heat-treated residual HCC cells via the inhibited POSTN expression and the increased apoptosis. CONCLUSIONS: Activated HSCs promote the tumor progression of heat-treated residual HCC through the release of POSTN, which could be inhibited by calcipotriol. Calcipotriol plus cisplatin could be used to thwart the accelerated progression of residual HCC after suboptimal heat treatment.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2018) studied Hepatocellular carcinoma. Calcipotriol plus cisplatin vs. Saline was evaluated on Tumor progression (in vivo tumor volume and in vitro malignant phenotypes). Calcipotriol plus cisplatin significantly suppressed the activated hepatic stellate cell-enhanced tumor progression of heat-treated residual hepatocellular carcinoma by inhibiting periostin expression and increasing apoptosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: